Literature DB >> 19355847

Oligomeric amyloid beta-protein as a therapeutic target in Alzheimer's disease: its significance based on its distinct localization and the occurrence of a familial variant form.

Kazuhiro Ito1, Ken-ichi Ishibashi, Takami Tomiyama, Tomohiro Umeda, Kei-ichi Yamamoto, Erika Kitajima, Toshiki Idomoto, Toshie Nagatomo, Hiroshi Mori.   

Abstract

Oligomer Abeta is the term utilized for multimeric but non-fibrillar forms of amyloid beta-protein (Abeta). The most prominent property of oligomer Abeta is considered to be its solubility and structure. Here, we examined the histochemical localization of oligomer Abeta in AD brains. At present, little information is available on the structure and function of cerebral oligomer Abeta. We therefore studied the molecular localization of oligomer Abeta using a newly generated polyclonal mouse antisera against a variant Abeta with a deletion mutation of the 22(nd) glutamate that we found recently in a patient with familial Alzheimer's disease. Intracellular as well as extracellular oligomer Abeta are herein discussed to define their structure and pathological roles in disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19355847     DOI: 10.2174/156720509787602889

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  1 in total

1.  Immunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease.

Authors:  Fernando Goñi; Frances Prelli; Yong Ji; Henrieta Scholtzova; Jing Yang; Yanjie Sun; Feng-Xia Liang; Regina Kascsak; Richard Kascsak; Pankaj Mehta; Thomas Wisniewski
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.